Sandoz, >98% (HPLC), powder

Sandoz, >98% (HPLC), powder

Stock Code: 3573935
Manufacturer Part No: S9318-25MG
Order Now for 7 day delivery
£945.75 (exc VAT) per 25MG
Quantity: - +

Application


Sandoz 58-035 was used to induce simultaneous activation of unfolded protein response (UPR) and pattern recognition receptors (PRRs) in mouse peritoneal macrophages.3


Biochem/physiol Actions


Sandoz 58-035 inhibits the accumulation of cholesteryl esters and inhibits the esterification of cholesterol by 95% in arterial smooth muscle cells in culture.1 It does not affect the triglyceride metabolism by the gut.2


Acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor.


Features and Benefits


This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.


Packaging


5, 25 mg in glass bottle

Colourwhite
Quality Level100
InChI keyNBYATBIMYLFITE-UHFFFAOYSA-N
InChI1S/C30H47NOSi/c1-5-6-7-8-9-10-11-15-23-33(3,4)24-22-30(32)31-29(28-16-13-12-14-17-28)25-27-20-18-26(2)19-21-27/h12-14,16-21,29H,5-11,15,22-25H2,1-4H3,(H,31,32)
ManufacturerSIGMA-ALDRICH
Formpowder
Assay>98% (HPLC)

There are no downloads for this product.